NR4A1 and cancer: Breast cancer (BC) represents the first diagnosis of cancer in women and the second-leading cause of cancer death; in the last five years, the incidence rates increased by 0.5 annually, mainly due to early-stage and hormone receptor (HoR) positive disease.